Your browser doesn't support javascript.
loading
MRI Treatment Response Assessment Maps (TRAMs) for differentiating recurrent glioblastoma from radiation necrosis.
Müller, Sebastian Johannes; Khadhraoui, Eya; Ganslandt, Oliver; Henkes, Hans; Gihr, Georg Alexander.
Afiliação
  • Müller SJ; Klinik Für Neuroradiologie, Klinikum-Stuttgart, Kriegsbergstr. 60, 70174, Stuttgart, Germany. sebastian.j.mueller@googlemail.com.
  • Khadhraoui E; Klinik Für Neuroradiologie, Klinikum-Stuttgart, Kriegsbergstr. 60, 70174, Stuttgart, Germany.
  • Ganslandt O; Abteilung Für Neurochirurgie, Klinikum-Stuttgart, Stuttgart, Germany.
  • Henkes H; Klinik Für Neuroradiologie, Klinikum-Stuttgart, Kriegsbergstr. 60, 70174, Stuttgart, Germany.
  • Gihr GA; Klinik Für Neuroradiologie, Klinikum-Stuttgart, Kriegsbergstr. 60, 70174, Stuttgart, Germany.
J Neurooncol ; 166(3): 513-521, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38261142
ABSTRACT

BACKGROUND:

MRI treatment response assessment maps (TRAMs) were introduced to distinguish recurrent malignant glioma from therapy related changes. TRAMs are calculated with two contrast-enhanced T1-weighted sequences and reflect the "late" wash-out (or contrast clearance) and wash-in of gadolinium. Vital tumor cells are assumed to produce a wash-out because of their high turnover rate and the associated hypervascularization, whereas contrast medium slowly accumulates in scar tissue. To examine the real value of this method, we compared TRAMs with the pathology findings obtained after a second biopsy or surgery when recurrence was suspected.

METHODS:

We retrospectively evaluated TRAMs in adult patients with histologically demonstrated glioblastoma, contrast-enhancing tissue and a pre-operative MRI between January 1, 2017, and December 31, 2022. Only patients with a second biopsy or surgery were evaluated. Volumes of the residual tumor, contrast clearance and contrast accumulation before the second surgery were analyzed.

RESULTS:

Among 339 patients with mGBM who underwent MRI, we identified 29 repeated surgeries/biopsies in 27 patients 59 ± 12 (mean ± standard deviation) years of age. Twenty-eight biopsies were from patients with recurrent glioblastoma histology, and only one was from a patient with radiation necrosis. We volumetrically evaluated the 29 pre-surgery TRAMs. In recurrent glioblastoma, the ratio of wash-out volume to tumor volume was 36 ± 17% (range 1-73%), and the ratio of the wash-out volume to the sum of wash-out and wash-in volumes was 48 ± 21% (range 22-92%). For the one biopsy with radiation necrosis, the ratios were 42% and 54%, respectively.

CONCLUSIONS:

Typical recurrent glioblastoma shows a > 20%ratio of the wash-out volume to the sum of wash-out and wash-in volumes. The one biopsy with radiation necrosis indicated that such necrosis can also produce high wash-out in individual cases. Nevertheless, the additional information provided by TRAMs increases the reliability of diagnosis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article